AgeX Therapeutics to Present at Metabesity 2019
ALAMEDA, Calif.–(BUSINESS WIRE)–AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company focused on developing therapeutics for human aging and…
Pharmaceuticals, Biotechnology and Life Sciences
ALAMEDA, Calif.–(BUSINESS WIRE)–AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company focused on developing therapeutics for human aging and…
ALAMEDA, Calif.–(BUSINESS WIRE)–AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company focused on developing therapeutics for human aging and…
TORONTO–(BUSINESS WIRE)–#FSDDF–FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”) today announced the appointment of…
TORONTO–(BUSINESS WIRE)–#FSDDF–FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”) today announced the appointment of…
DUBLIN–(BUSINESS WIRE)–The “TNF Alpha Inhibitors Market By Drug Class (Adalimumab, Certolizumab Pegol, Etanercept, Golimumab, Infliximab), By Pipeline Analysis (Phase I,…
DUBLIN–(BUSINESS WIRE)–The “TNF Alpha Inhibitors Market By Drug Class (Adalimumab, Certolizumab Pegol, Etanercept, Golimumab, Infliximab), By Pipeline Analysis (Phase I,…
LONDON–(BUSINESS WIRE)–#Chemicals–The polytetrafluoroethylene (PTFE) market size is expected to post a CAGR over 7% during the period 2019-2023, according to…
LONDON–(BUSINESS WIRE)–#Chemicals–The polytetrafluoroethylene (PTFE) market size is expected to post a CAGR over 7% during the period 2019-2023, according to…
DUBLIN–(BUSINESS WIRE)–The “Alzheimer’s Therapeutics Market By Molecule Type (Cholinesterase Inhibitors, NMDA Receptor Antagonists, and Others), By Distribution Channel (Hospital Pharmacies,…
DUBLIN–(BUSINESS WIRE)–The “Alzheimer’s Therapeutics Market By Molecule Type (Cholinesterase Inhibitors, NMDA Receptor Antagonists, and Others), By Distribution Channel (Hospital Pharmacies,…